Supplementary Appendix. 1. Life cycle, epidemiology and clinical aspects of malaria

Haema 2019; 10(2):66

Konstantinos Liapis

Consultant Haematologist, Georgios Gennimatas Hospital

Full PDF |

1. Generalised life cycle (Figure S1)1,2

The disease is transmitted through sporozoites injected by the female anopheline mosquito into skin capillaries, or through blood transfusion. Sporozoites (2) enter the liver parenchyma cells where they grow asexually by schizogony into the first generation of pre-erythrocytic schizonts (3). These give rise to thousands of cryptozoites (merozoites), which invade red blood cells by binding to ‘receptors’ on red cell membrane (Duffy blood group FyaFyb for P. vivax; glycophorin Β and C for P. falciparum), to develop into the asexual erythrocytic cycle (4). Some sporozoites P. vivax and P. ovale in the hepatocytes stay dormant (hypnozoite) to mature after an interval of weeks, months or even years into secondary exo-erythrocytic schizonts (3a, 3b). The successive waves of cryptozoites emerging from these give rise to relapse infections in the blood after months or years. Intraerythrocytic parasites, now named young trophozoites, acquire ring shapes and devour intracellular haemoglobin, excreting as they do so lumps of brownish ferrihaeme called malaria pigment or haemozoin or haematin. (Note: intracellular plasmodia protect themselves against free radical oxygen species released during haemozoin production by using host cell superoxide dismutase enzyme). The morphology of later blood stages differs from one species to another. As ring shaped trophozoites grow, they assume bulky or amoeboid shapes with enlarged chromatin mass (late trophozoites). The trophozoite nuclei undergo segmentation and division (schizogony or asexual erythrocytic cycle) to form multinucleated schizonts (early schizonts). Cytoplasm condenses around each doughter nucleus, as the schizont matures, to form late schizonts (mature schizonts) which contain well-formed merozoites. As the infected red cells disrupt, the cargo of 6 to 24 merozoites is now released to infect other red blood cells. Thus a new cycle of red cell infection and destruction is initiated. Some blood stages mature to form sexual forms, the macro (female) and micro (male) gametocytes (5). These enter the mosquito where the males exflagellate to fertilise the females (6). The ookinete thus produced forms oocysts on the outside of the midgut (7). Sporozoites develop in the oocysts (8,9). The sporozoites enter the mosquito salivary glands, where they are ready to infect a new host (2). P. falciparum and P. malaria do not form hypnozoites and stages 3a and 3b do not exist and true relapses do not occur.

Figure S1. Life cycle of P. vivax and P. ovale.

Recrudescence may occur in any type of malaria infection but true relapses occur only in tertian fever (P. vivax, P. ovale). Relapses develop from the persistence of sporozoites in the liver cells (hypnozoites). These dormant parasites may develop into tissue schizonts (reactivate) over a period of time ranging from a few months up to five years since initial infection, and the schizonts provide a source of new merozoites to re-invade red blood cells. The mechanisms that trigger hypnozoite reactivation and relapse of malaria are unknown but in some cases this follows a viral or microbial infection. The hypnozoites are also responsible for the long incubation period of tertian malaria (up to 9 months after the bite of anopheles in an endemic area) e.g. an infection contracted in the fall does not produce initial symptoms until the following spring, 7-9 months later.

Recrudescence in the blood film may occur after an infection which was treated with anti-malarials (i.e. non-immunologically cured infection), for up to 1 year later in the case of P. falciparum, and decades after the initial infection in the case of P. malariae. Note: P. malariae is associated with low-grade, prolonged parasitaemia.

2. Distribution map of malaria (Figure S2)1-4

In spite of intensive control measures over the past 50 years, malaria is still widely distributed in the tropics and subtropics (nearly half of the global population lives in endemic regions, and ~47% of the world’s countries have a malaria problem). The breakdown of large scale vector control operations and the emergence of multiple drug resistance in some of the parasites has led to an increase in the incidence of malaria in some regions.

Figure S2. Distribution map of malaria.

3. Characteristics of the three medically important mosquito genera (Figure S3)

There are 420 species of anopheles mosquito, of these 40 are malaria vectors. Anopheles gambiae is the most dangerous malaria vector in tropical Africa.

 – Anopheles is active during night (nocturnal) or twilight
 – Culex is nocturnal
 – Aedes is active during day (diurnal). Aedes spp. can act as vectors for arboviruses such as dengue, chikungunya, and Zika viruses.

Figure S3. Medically important mosquito genera.

4. Clinical information1-10

The typical clinical picture is paroxysmal rigor-fever-sweats, splenomegaly and hepatomegaly (due to hypertrophy of the reticuloendothelial system). Malaria is classified as:

 – tertian fever (P. vivax, P. ovale) and malignant tertian fever (P. falciparum): 48 hours between paroxysms (the asexual blood stages of P. falciparum, P. vivax, and P. ovale require 48 hours to complete their schizogony; fever is produced when schizonts mature i.e. at 48 hour intervals)
 – quartan fever (P. malariae): 72 hours between paroxysms

The distinction based on the pattern of fever is not practical; usually acute malaria is an undifferentiated febrile illness without a typical pattern of fever.

The most common species are P. falciparum and P. vivax. Travel history and epidemiology offer useful clues to diagnosis:

tropical Africa (e.g. Cameroon)→P. falciparum
nothern Africa → P. vivax
P. vivax 
relatively uncommon in sub-Saharan Africa
Middle East (e.g. Afghanistan) P. vivax > P. falciparum
South-East Asia P. vivax ~ P. falciparum
Central America the usual species is P. vivax
South America both P. vivax and P. falciparum

are common species

  – P. ovale à is found mainly in (West) Africa
 – P. falciparum à maximum incidence in tropical Africa, Haiti, New Guinea, and the Western Pacific Islands

The global distribution of Plasmodium falciparum and Plasmodium vivax malaria in 2010 is shown in Figure S4

Figure S4. Global distribution of malaria (2010).

The characteristic immunological response in malaria is an increase in the IgG level. Cellular immunity also plays a role (Th1 responses e.g. INFγ).

HIV infection (common in migrants from sub-Saharan Africa with malaria) and iatrogenic immunosuppression do not predispose to malaria, do not increase the severity of malaria, and they are not associated with failure of antimalarial treatment (although more delayed clearance of the parasite may be observed). Malaria is not an opportunistic infection.

Splenectomy and hyposplenism are associated with increased severity of malaria (hyposplenic individuals should avoid travelling to areas of high endemicity). Pregnancy in also associated with increased severity of malaria (danger for mother and baby).

Remember: malaria and babesiosis can cause extreme parasitaemia and fatal haemolytic anaemia in hyposplenic individuals.

Individuals (>5 years old) living for a long time continuously in area of high endemicity or migrants originating from areas of high endemicity may have become semi-immune to malaria, and thus may have low-grade P. falciparum parasitaemia without fever or complications (i.e. asymptomatic infection) or an atypical clinical picture (e.g. unexpected identification of P. falciparum in the blood film of a migrant from Senegal without fever). In such cases, it is possible that fever may not be due to malaria, even though rare malaria parasites were found in the blood film! It has been reported that high levels of PfHRP-2 protein in plasma and fundal changes (e.g. Roth spots and exudates) may differentiate between severe malaria and other serious conditions with intercurrent parasitaemia (῾random᾿ parasitaemia).

Delays in the diagnosis of malaria often occur due to the diagnosis not being considered promptly; non-specific laboratory clues include elevated LDH, presence of atypical lymphocytes, elevated AST, and thrombocytopenia (present in 60‒80% of cases).

The differential diagnosis of fever without focal signs in returning travellers and migrants should include:

– malaria
– typhoid fever
– influenza
– dengue
may all be accompanied by abnormal counts e.g. leukopenia, thrombocytopenia and anaemia

Typhoid fever (enteric fever) has the same geographical distribution with P. falciparum and, like malaria, typhoid fever can present with persistent fever, frontal headache, splenomegaly, and abdominal pain or abdominal tenderness (diffuse or right-upper quadrant); a dry cough is also common. Typhoid fever is frequently accompanied by leukopenia and eosinopenia. Generalised lymphadenopathy is uncommon in typhoid.

In the tropics, influenza viruses circulate throughout the year (i.e. influenza is endemic throughout the year). From a haematologist’s standpoint, severe H1N1 influenza is associated with haemophagocytic syndrome.

Dengue concerns travellers to South-East Asia (e.g. Singapore, Hong Kong), India, and the Caribbean (Figure S5). Unlike malaria, dengue frequently presents with an erythematous generalised rash and a large number of atypical (reactive) lymphocytes in the blood film (ddx: infectious mononucleosis). Arthralgia, headache, and thrombocytopenia are very common; thrombocytopenia may be severe in dengue haemorrhagic fever (DHF). Unlike malaria there is no jaundice in dengue (even in DHF). In uncomplicated dengue, CRP is typically normal. In contrast, CRP may be increased in malaria. Headache (retro-orbital), generalised lymphadenopathy and/or splenomegaly may be present.

Figure S5. Distribution map of dengue.

 – in every patient who returns from the tropics with fever, regardless of the clinical symptoms or signs you should rule out malaria (P. falciparum may manifest as acute febrile gastroenteritis, traveller’s diarrhoea, atypical abdominal pain and fever, dry cough and fever, severe headache and fever, flu-like syndrome, or severe sepsis/septic shock). Arthralgia, myalgia, and nausea are very common symptoms of malaria.
 – malaria does not cause any lymphadenopathy or rash.
 – travellers who develop a fever >7-10 days after their return are unlikely to have dengue or chikungunya fever but they may have malaria.

  1. Peters W, Gilles HM. A colour atlas of tropical medicine and parasitology. 2nd ed. London: Wolfe; c1981.
  2. Peters W, Pasvol G. A colour atlas of tropical medicine and parasitology. 6th ed. London: Mosby Elsevier; c2007.
  3. Cook GC, Zumla AI. Manson’s tropical diseases. 22nd ed. London: Εlsevier Saunders; c2008.
  4. Farrar J, Hotez P, Junghanss T, Kang G, Lalloo D, White N. Manson’s tropical diseases. 23rd ed. London: Εlsevier Saunders; c2014.
  5. Loffler H, Rastetter J, Haferlach T. Atlas of clinical hematology. 6th ed. Berlin Heidelberg: Springer-Verlag; c2005.
  6. Spira AM. Assessment of travellers who return home ill. Lancet. 2003 Apr;361(9367):1459-69.
  7. Ryan ET, Wilson ME, Kain KC. Illness after international travel. N Engl J Med. 2002 Aug;347(7):505-16.
  8. Vinetz JM, Li J, McCutchan TF, Kaslow DC. Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly. N Engl J Med. 1998 Feb;338(6):367-71.
  9. Ashley EA, Pyae Phyo A, Woodrow CJ. Malaria. Lancet. 2018 Apr;391(10130):1608-21.
  10. Guzman MG, Harris E. Dengue. Lancet. 2015 Jan;385(9966): 453-65.